NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Start Multiple Choice Practice Test
Start Flash Cards

Practice this question and more.

Which of the following is NOT an indication for Palivizumab in children?

  1. Premature infants born at < 29 months

  2. Infants < 6 months with chronic lung disease

  3. Infants < 12 months with certain heart conditions

  4. All are indications for Palivizumab

The correct answer is: Infants < 6 months with chronic lung disease

Palivizumab is a monoclonal antibody used to prevent severe lower respiratory tract infections caused by respiratory syncytial virus (RSV) in certain high-risk infants and children. The indications for Palivizumab include premature infants born at < 29 weeks, infants < 12 months with certain heart conditions, and premature infants born at < 32 weeks with chronic lung disease. However, infants < 6 months with chronic lung disease are not indicated for Palivizumab. This is why option B is the correct answer because it is the only one that does not represent a valid indication for Palivizumab use in children.

More Questions Like This